|
Volumn 20, Issue 8, 2000, Pages 687-695
|
Tolerability of sumatriptan: Clinical trials and post-marketing experience
d
IL
(United States)
|
Author keywords
Migraine; Safety; Sumatriptan
|
Indexed keywords
SUMATRIPTAN;
ARTICLE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DRUG FORMULATION;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
DRUG TOLERABILITY;
HEART MUSCLE ISCHEMIA;
HUMAN;
INJECTION SITE;
MIGRAINE;
PATIENT SELECTION;
PRESCRIPTION;
RISK BENEFIT ANALYSIS;
SKIN TINGLING;
THORAX PAIN;
CARDIOVASCULAR DISEASES;
CEREBROVASCULAR DISORDERS;
CLINICAL TRIALS;
HUMANS;
MIGRAINE DISORDERS;
PRODUCT SURVEILLANCE, POSTMARKETING;
SUMATRIPTAN;
|
EID: 0034495090
PISSN: 03331024
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1468-2982.2000.00116.x Document Type: Article |
Times cited : (116)
|
References (34)
|